🇺🇸 FDA
Patent

US 8299033

Iodo-hexose compounds useful to treat cancer

granted A61PA61P35/00

Quick answer

US patent 8299033 (Iodo-hexose compounds useful to treat cancer) held by The Board of Regents of the University of Texas System expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 30 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P35/00